Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 30Genitourinary 25Other 13Lymphoid 13Thoracic 12Gastrointestinal 9Classical hematology 8Plasma cell 6Other hematologic neoplasm 6Head & Neck 6CNS 3NET 2Endocrine 2Dermatologic 2Sarcoma 1Myeloid 1Gynecologic 1

Conditions

Neuroendocrine Tumors 531Multiple Endocrine Neoplasia Type 1 187Pituitary Neoplasms 186Thyroid Cancer, Papillary 178Pheochromocytoma 152Carcinoma, Neuroendocrine 140Thyroid Neoplasms 130Neoplasms 107Carcinoid Tumor 99Paraganglioma 98Adrenocortical Carcinoma 92Thyroid Carcinoma, Anaplastic 82Pancreatic Neoplasms 69Neoplasm Metastasis 67Insulinoma 61Adrenal Gland Neoplasms 61Gastro-enteropancreatic neuroendocrine tumor 58Carcinoma, Medullary 58Adenocarcinoma, Follicular 58Carcinoma, Non-Small-Cell Lung 57Breast Neoplasms 56Adenoma, Islet Cell 56Lung Neoplasms 50Sarcoma 49Colorectal Neoplasms 49Carcinoma, Renal Cell 49Melanoma 47Small Cell Lung Carcinoma 45Prostatic Neoplasms 44Head and Neck Neoplasms 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Failure × Endocrine × Clear all
NCT07450287 2026-03-04

CardioNETPOL

National Institute of Cardiology, Warsaw, Poland

Not yet recruiting
120 enrolled
EndocrineNET

Carcinoid Heart Disease, Heart Failure, Heart Valve Diseases, Neuroendocrine Tumors, Serotonin Syndrome

NCT01730417 2012-11-21

mIBG

Duke University

Phase 1 Completed
12 enrolled
EndocrineNET

Heart Failure, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡